Multicomponent Nanomedicines for Photodynamic Diagnosis and Photodynamic Therapy

Dear Colleagues,

Even though different drug discovery studies are composed of a single chemical entity, most analysts believe that “the one drug to fit all” approach will be unsustainable in the future as many diseases are multifactorial in nature and individual molecular targets cannot usually combat multifactorial diseases wherein multiple tissues or cell types are affected. Therefore, multi-drug or multi-target therapies are considered to be advantageous for multifactorial diseases. Our focus of this Special Issue is on multicomponent targeting drug delivery for photodynamic diagnosis (PDD) and photodynamic therapy (PDT) of oncological diseases. In addition, nanotechnology integrated with PDD and PDT strategies is a promising approach for the diagnosis and treatment of accurate lesions. In this regard, this Special Issue aims to publish high-quality research papers and reviews focusing on the design of smart nanomedicines in the PDD and PDT of various oncological tumors. Research topics include but are not limited to the following:

• Photodynamic therapy;
• Photodynamic diagnosis;
• Oncological diseases;
• Multicomponent nanomedicines;
• Multi-target therapies;
• Drug delivery;
• Targeting antibodies/aptamers/peptides.

Prof. Dr. Heidi Abrahamse
Dr. Hanieh Montaseri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.